Clinical Trials on Football Players in New Zealand
Total 1 results
-
Heidelberg Engineering GmbHCompletedRetinal Layer SeparationUnited States
Sponsors and Collaborators
- Kingfisher Healthcare
- Bart CJM Fauser
- Regional Cancer Hospital - Szczecin
- Collaboration for Leadership in Applied Health Research and Care (CLAHRC), UK
- Oluwasegun Aremu
- Cambia Health Solutions
- Medtronic Minimed
- MA Abdelreheem
- Hospital de Base de São Jose do Rio Preto
- Almughtaribeen University
- The Fond of Jørgen Holm and Elisa F. Hansen
- Luxembourg National Research Fund
- Hans-Joachim Schmoll, MD
- Wellth Inc.
- Universidade Federal do Amazonas
- RCCS Monzino Hospital, Milan, Italy
- Bakery Hinkel
- Mount Sinai Rehabilitation Hospital
- Universtiy of Mississippi Medical Center
- Washington State Department of Children, Youth and Families
- View Full List
Medical Conditions
- Pelvic Floor Ptosis
- Sacrospinous Ligament Fixation
- Hypercholesterolemia in Coronaory Heart Disease
- Stage IIB Cervical Cancer AJCC v8
- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- Distal Ulna Fracture
- Relapsed Lymphomas
- Diarrhea Caused by Drug
- Acute Spinal Paralysis
- Somatic Dysfunction of Cranial Region
- Atrial Septal Defect
- Breast Atypical Lobular Hyperplasia
- Resection and Whipple Procedures
- Functional Iron Deficiency
- PICC-associated Thrombosis
- Older Diabetic Persons Without Dementia
- Medicaid Expansion, High-value Care, Low-value Care
- Badly Decayed Teeth, Teeth Restored With Large Filling Restorations or Endodontically Treated Teeth
- Squamous Cell Carcinoma, Unknown Primary
- Globoid Leukodystrophy
- View Full List
Drug Interventions
- Lanadelumab Injection [Takhzyro]
- Hipnos 5
- Silybin 94 mg + vitamin E 90 mg + phospholipids 194 mg
- ALK Alutard 5-grasses and birch
- Femoston
- Insulin Lispro
- Melphalan
- Morphine prolonged release
- Onivyde
- Recombinant human interleukin-2(rhIL-2)
- ATI-2042 200 mg
- Bupivacain
- Deutetrabenazine 6 MG
- Cisplatin
- Pravastatin
- Fluoride and Silica
- Entresto
- Itraconazole 200 mg
- ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)
- Oxytocin
- View Full List
CROs by country
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Oman
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Panama
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Peru
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Thailand
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Uzbekistan
- CRO list by country